The role of mammalian target of rapamycin (mTOR) in the regulation of pancreatic β-cell mass: implications in the development of type-2 diabetes

作者: Jianling Xie , Terence P. Herbert

DOI: 10.1007/S00018-011-0874-4

关键词:

摘要: Type-2 diabetes mellitus (T2DM) is a disorder that characterized by high blood glucose concentration in the context of insulin resistance and/or relative deficiency. It causes metabolic changes lead to damage and functional impairment organs tissues resulting increased morbidity mortality. this form whose prevalence increasing at an alarming rate due ‘obesity epidemic’, as obesity key risk factor development resistance. However, majority individuals who have do not develop compensatory increase secretion response demand. This adaptive sustained both β-cell function mass. Importantly, there evidence Serine/Threonine kinase mammalian target rapamycin (mTOR) plays role regulation mass therefore likely critical adaptation. Therefore, primary focus review summarize our current understanding mTOR stimulating pancreatic thus, prevention type-2 diabetes.

参考文章(189)
Mario Pende, Sara C. Kozma, Muriel Jaquet, Viola Oorschot, Rémy Burcelin, Yannick Le Marchand-Brustel, Judith Klumperman, Bernard Thorens, George Thomas, Hypoinsulinaemia, glucose intolerance and diminished beta-cell size in S6K1-deficient mice. Nature. ,vol. 408, pp. 994- 997 ,(2000) , 10.1038/35050135
Kyoko Tsukiyama-Kohara, Francis Poulin, Michinori Kohara, Christine T. DeMaria, Alan Cheng, Zhidan Wu, Anne-Claude Gingras, Asao Katsume, Mounib Elchebly, Bruce M. Spiegelman, Mary-Ellen Harper, Michel L. Tremblay, Nahum Sonenberg, Adipose tissue reduction in mice lacking the translational inhibitor 4E-BP1 Nature Medicine. ,vol. 7, pp. 1128- 1132 ,(2001) , 10.1038/NM1001-1128
Mathieu Miron, Javier Verdú, Pascal E.D. Lachance, Morris J. Birnbaum, Paul F. Lasko, Nahum Sonenberg, The translational inhibitor 4E-BP is an effector of PI(3)K/Akt signalling and cell growth in Drosophila. Nature Cell Biology. ,vol. 3, pp. 596- 601 ,(2001) , 10.1038/35078571
R. B. Pearson, P. B. Dennis, J. W. Han, N. A. Williamson, S. C. Kozma, R. E. Wettenhall, G. Thomas, The principal target of rapamycin‐induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. The EMBO Journal. ,vol. 14, pp. 5279- 5287 ,(1995) , 10.1002/J.1460-2075.1995.TB00212.X
John T. Cunningham, Joseph T. Rodgers, Daniel H. Arlow, Francisca Vazquez, Vamsi K. Mootha, Pere Puigserver, mTOR controls mitochondrial oxidative function through a YY1–PGC-1α transcriptional complex Nature. ,vol. 450, pp. 736- 740 ,(2007) , 10.1038/NATURE06322
Marc Prentki, Christopher J Nolan, Islet β cell failure in type 2 diabetes Journal of Clinical Investigation. ,vol. 116, pp. 1802- 1812 ,(2006) , 10.1172/JCI29103
Robyn L. Tuttle, Navdeep S. Gill, William Pugh, Jean-Pyo Lee, Brigitte Koeberlein, Emma E. Furth, Kenneth S. Polonsky, Ali Naji, Morris J. Birnbaum, Regulation of pancreatic beta-cell growth and survival by the serine/threonine protein kinase Akt1/PKBalpha. Nature Medicine. ,vol. 7, pp. 1133- 1137 ,(2001) , 10.1038/NM1001-1133
Ian G. Ganley, Du H. Lam, Junru Wang, Xiaojun Ding, She Chen, Xuejun Jiang, ULK1·ATG13·FIP200 Complex Mediates mTOR Signaling and Is Essential for Autophagy Journal of Biological Chemistry. ,vol. 284, pp. 12297- 12305 ,(2009) , 10.1074/JBC.M900573200
L. Beretta, A. C. Gingras, Y. V. Svitkin, M. N. Hall, N. Sonenberg, Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation. The EMBO Journal. ,vol. 15, pp. 658- 664 ,(1996) , 10.1002/J.1460-2075.1996.TB00398.X